News – AMSL Diabetes

News

News and Media

News and Media
2021 2020 2019 2018
News and Media

Update Prompts Additional Step in Setting up Dexcom Account for some New Customers

September 2021 Following an update to the Dexcom account creation interface from 9th of September 2021, selected new Dexcom G5 Mobile customers may need to complete an additional step when creating their Dexcom account. This update will not affect existing Dexcom G5 Mobile customers. For further information, please refer to this document. The update introduces …

15.09.2021

Dexcom, Inc. acquires AMSL and NZMS

August 2021 Richard Plowright, Managing Director and Owner of Australasian Medical & Scientific Limited (AMSL) and New Zealand Medical & Scientific (NZMS) has announced his retirement, after over 30 years of providing the Australasian market with access to leading edge healthcare solutions from all over the world. As of the 1st August 2021, Richard has …

05.08.2021

Tandem t:slim X2 Insulin Pump Suspension Lifted

7th April 2021 The Therapeutic Goods Administration (TGA) suspension of the ARTG entry for the Tandem Diabetes Care t:slim X2 insulin pump has officially been lifted. AMSL Diabetes and Tandem Diabetes Care have been in discussions with the TGA and have now successfully addressed their concerns for the t:slim X2 insulin pump. For more information …

07.04.2021

Tandem t:slim X2 Insulin Pump with Dexcom G5 Mobile Integration Supply Update

29th March 2021 As of 29th March 2021, AMSL Diabetes has discontinued the sale of the t:slim X2 insulin pump with Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) integration. This announcement does not affect the supply of the t:slim X2 insulin pump with Basal-IQ™ technology and any subsequent versions of the pump. Existing customers will …

29.03.2021

The Australian Government has updated the NDSS CGM Subsidy Initiative

15th January 2021 The Australian Government has updated the NDSS CGM Subsidy Initiative to include the NEW Dexcom G6 Continuous Glucose Monitoring System. As of Monday 18th of January 2021,  if you are using a Tandem t:slim X2 insulin pump and are eligible for the NDSS CGM Subsidy Initiative you can now have access to …

15.01.2021

Tandem Suspension Notice (Last Updated 1 April 2021)

24th November 2020 Recently the Therapeutic Goods Administration (TGA) expressed concern about the Tandem Diabetes Care t:slim X2 insulin pump. AMSL Diabetes and Tandem Diabetes Care have been in discussions with the TGA to address their concern. However the TGA have informed us of their intent to temporarily suspend the ARTG entry for the t:slim …

24.11.2020

Dexcom G4 PLATINUM manufactured by Dexcom – Supply Update

Dexcom G4 PLATINUM manufactured by Dexcom has been discontinued for sales directly from AMSL Diabetes.

25.09.2020

t:slim X2 insulin pump with NEW Basal-IQ technology

Basal-IQ technology is now available in Australia!  The t:slim X2 insulin pump with Basal-IQ technology is compatible with the new Dexcom G6 CGM System.

19.08.2020

Dexcom G4 PLATINUM & Dexcom G5 Mobile Update

On the 2nd April 2020, Dexcom announced the upcoming obsolescence for Dexcom G4 PLATINUM and Dexcom G5 Mobile at dexcom.com/obsolescence. This specific announcement and timeline is only applicable to residents of the United States.

06.04.2020

Important Update: AMSL’s Commitment during COVID-19

Important Message from AMSL General Manager, Ian Slater on COVID-19 23rd March 2020 The impact of COVID-19 has been unprecedented as it continues to affect people and organisations around the world. The Federal Government, State Governments and Health Authorities continue to provide detailed guidelines on how to mitigate risks and ensure containment. We encourage all …

23.03.2020

Dexcom G6 CGM System Update

Sydney, Australia, March 2020 The Dexcom G6 Continuous Glucose Monitoring (CGM) System, has been registered in Australia (ARTG 330535).                                                                 Dexcom G6 represents the latest …

04.03.2020

The Australian Government Simplifies the Clinical Eligibility Criteria for the Continuous Glucose Monitoring (CGM) Initiative

Sydney, Australia, March 2020 The Australian Government is simplifying the clinical eligibility criteria for the Continuous Glucose Monitoring (CGM) Initiative from the 1st of March, 2020. This will allow people with type 1 diabetes under the age of 21, and those over the age of 21 who have valid concessional status to access fully subsidised CGM …

02.03.2020

AMSL Diabetes Partner with MannKind Corporation

Sydney, Australia, May 2019 AMSL Diabetes are excited to announce that they have signed a distribution agreement with MannKind Corporation (NASDAQ: MNKD) to introduce their patient-focused therapies to the Australian market. The exclusive partnership is set to benefit Australian diabetes patients by offering a new innovative technology solution for their diabetes management. “We are excited …

17.05.2019

AMSL Diabetes to distribute MedAngel ONE in Australia

Sydney, Australia, April 2019 AMSL Diabetes are delighted to announce that they have agreed to distribute MedAngel products in Australia.                                                                        …

01.04.2019

NDSS Blood Glucose Strips Review Press Release

Sydney, Australia, November 2018 Inclusion of LifeScan OneTouch Blood Glucose Test Strips on the NDSS Product Schedule.                                                                   The Australian Government recently undertook a …

01.11.2018

Tandem Diabetes Care Partnership Announcement

Sydney, Australia, August 2018 AMSL Diabetes are delighted to announce they have partnered with Tandem Diabetes Care®, Inc. AMSL Diabetes have partnered with Tandem Diabetes Care, to introduce their innovative product range to the Australian market for the very first time. The exclusive partnership is set to benefit Australian type 1 diabetes patients by offering …

25.08.2018

Stay informed with AMSL Diabetes

Now you can get all the latest news and updates of our products, events and resources right into your inbox.

Something went wrong. Please try again later!

Send AMSL Diabetes a message

We are always happy to help, send us a message or enquiry

Back to top